Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Neuroscience

• Publication date

  2018-08-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41593-018-0238-6PMID 30258241PMCID PMC6375686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression

  2018cited by this paper
• Infectious prions do not induce Aβ deposition in an in vivo seeding model

  2018cited by this paper
• Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain

  2018cited by this paper
• Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo

  2018cited by this paper
• Unconventional Secretion Mediates the Trans-cellular Spreading of Tau.

  2018cited by this paper
• Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

  2018cited by this paper
• Extracellular α-synuclein levels are regulated by neuronal activity

  2018cited by this paper
• Molecular subtypes of Alzheimer’s disease

  2018cited by this paper
• Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity

  2018cited by this paper
• Fatal Aβ cerebral amyloid angiopathy 4 decades after a dural graft at the age of 2 years

  2018cited by this paper
• Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)

  2018cited by this paper
• Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer’s disease

  2018cited by this paper
• Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study

  2018cited by this paper
• Cellular Milieu Imparts Distinct Pathological α-Synuclein Strains in α-Synucleinopathies

  2018cited by this paper
• Neuropathology of iatrogenic Creutzfeldt–Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology

  2018cited by this paper
• The Structure of PrPSc Prions

  2018cited by this paper
• Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain

  2017cited by this paper
• Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

  2017cited by this paper
• Parkinson's Disease Is Not Simply a Prion Disorder

  2017cited by this paper
• Cryo-EM structures of Tau filaments from Alzheimer’s disease brain

  2017cited by this paper
• Aβ seeding potency peaks in the early stages of cerebral β‐amyloidosis

  2017cited by this paper
• Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease

  2017cited by this paper
• Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue

  2017cited by this paper
• Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease

  2017cited by this paper
• Familial Parkinson’s point mutation abolishes multiple system atrophy prion replication

  2017cited by this paper
• MSA prions exhibit remarkable stability and resistance to inactivation

  2017cited by this paper
• A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.

  2017cited by this paper
• Analysis of Amyloid-β Pathology Spread in Mouse Models Suggests Spread Is Driven by Spatial Proximity, Not Connectivity

  2017cited by this paper
• ‘Prion‐like’ propagation of the synucleinopathy of M83 transgenic mice depends on the mouse genotype and type of inoculum

  2017cited by this paper
• Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK

  2017cited by this paper
• Antibodies inhibit transmission and aggregation of C9orf72 poly‐GA dipeptide repeat proteins

  2017cited by this paper
• Fibril structure of amyloid-β(1–42) by cryo–electron microscopy

  2017cited by this paper
• Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation

  2017cited by this paper
• Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting.

  2016cited by this paper
• Human-to-mouse prion-like propagation of mutant huntingtin protein

  2016cited by this paper
• Deep clinical and neuropathological phenotyping of Pick disease

  2016cited by this paper
• Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease

  2016cited by this paper
• Structural Variation in Amyloid-β Fibrils from Alzheimer’s Disease Clinical Subtypes

  2016cited by this paper
• Mammalian prions and their wider relevance in neurodegenerative diseases

  2016cited by this paper
• Highly potent intracellular membrane-associated Aβ seeds

  2016cited by this paper
• Dura mater is a potential source of Aβ seeds

  2016cited by this paper
• Insights into Mechanisms of Chronic Neurodegeneration

  2016cited by this paper
• Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice

  2016cited by this paper
• Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.

  2016cited by this paper
• Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo

  2016cited by this paper
• Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils

  2016cited by this paper
• Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease

  2016cited by this paper
• Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1

  2016cited by this paper
• A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease

  2016cited by this paper
• Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex

  2016cited by this paper
• Neuronal activity enhances tau propagation and tau pathology in vivo

  2016cited by this paper
• Tau Oligomers Derived from Traumatic Brain Injury Cause Cognitive Impairment and Accelerate Onset of Pathology in Htau Mice

  2016cited by this paper
• Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3

  2016cited by this paper
• Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells

  2016cited by this paper
• Role of Prion Replication in the Strain-dependent Brain Regional Distribution of Prions*

  2016cited by this paper
• Significant association of cadaveric dura mater grafting with subpial Aβ deposition and meningeal amyloid angiopathy

  2016cited by this paper
• The neuritic plaque facilitates pathological conversion of tau in an Alzheimer's disease mouse model

  2016cited by this paper
• Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathology

  2016cited by this paper
• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

  2016cited by this paper
• Conversion of Synthetic Aβ to In Vivo Active Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model

  2016cited by this paper
• Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau

  2016cited by this paper
• Neurodegenerative diseases: expanding the prion concept.

  2015cited by this paper
• Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein

  2015cited by this paper
• Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC’s afferent and efferent connections

  2015cited by this paper
• A new prion disease: relationship with central and peripheral amyloidoses

  2015cited by this paper
• Progression of Seed‐Induced Aβ Deposition within the Limbic Connectome

  2015cited by this paper
• Depletion of microglia and inhibition of exosome synthesis halt tau propagation

  2015cited by this paper
• Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice

  2015cited by this paper
• Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

  2015cited by this paper
• Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy

  2015cited by this paper
• Cancer: The complex seeds of metastasis

  2015cited by this paper
• Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

  2015cited by this paper
• On the central role of brain connectivity in neurodegenerative disease progression

  2015cited by this paper
• Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation*

  2015cited by this paper
• The biology of proteostasis in aging and disease.

  2015cited by this paper
• Persistence of Aβ seeds in APP null mouse brain

  2015cited by this paper
• Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

  2015cited by this paper
• Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains

  2015cited by this paper
• Spreading of pathology in neurodegenerative diseases: a focus on human studies

  2015cited by this paper
• α-Synuclein strains cause distinct synucleinopathies after local and systemic administration

  2015cited by this paper
• Neuronal activity regulates extracellular tau in vivo

  2014cited by this paper
• Distinct patterns of spread of prion infection in brains of mice expressing anchorless or anchored forms of prion protein

  2014cited by this paper
• Aβ seeds resist inactivation by formaldehyde

  2014cited by this paper
• Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid.

  2014cited by this paper
• Mutant huntingtin is present in neuronal grafts in huntington disease patients

  2014cited by this paper
• Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance.

  2014cited by this paper
• Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients

  2014cited by this paper
• Experimental transmissibility of mutant SOD1 motor neuron disease

  2014cited by this paper
• Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice

  2014cited by this paper
• Pathological alpha-synuclein propagates through neural networks

  2014cited by this paper
• Multiple Factors Contribute to the Peripheral Induction of Cerebral β-Amyloidosis

  2014cited by this paper
• Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease

  2014cited by this paper
• A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

  2014cited by this paper
• Synthesis of High Titer Infectious Prions with Cofactor Molecules*

  2014cited by this paper
• Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys

  2014cited by this paper
• Formaldehyde-fixed brain tissue from spontaneously ill α-synuclein transgenic mice induces fatal α-synucleinopathy in transgenic hosts

  2014cited by this paper
• Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates

  2014cited by this paper
• Distinct tau prion strains propagate in cells and mice and define different tauopathies.

  2014cited by this paper
• Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice

  2013cited by this paper
• Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.

  2013cited by this paper

• Neuronal subtype governs amyloid structure, cellular response, and cognitive outcome in genetically targeted APP mouse models

  2026cites this paper
• Mapping cellular vulnerability in Parkinson’s disease using retro-AAVs and preformed α-synuclein fibrils

  2026cites this paper
• Protein disulfide isomerase dissolves and detoxifies oligomeric assemblies of amyloid beta peptide.

  2026cites this paper
• Impact of Klotho genotype on lactylation in Alzheimer's disease and mechanistic insights.

  2026cites this paper
• CG-RecNet: a gated and attention-fused deep learning framework for label-free classification of neural stem cell differentiation via imaging flow cytometry.

  2026cites this paper
• Microengineering of the capillary interface of midbrain dopaminergic neurons to study Parkinson’s disease vascular alterations

  2026cites this paper
• Are neurodegenerative diseases late-onset neurodevelopmental disorders? Tracing the developmental origins of neuronal vulnerability

  2026cites this paper
• Small molecule ensembles reshape amyloid aggregation landscapes

  2026cites this paper
• Astrocytic lysosome deficits reduce alpha-synuclein degradation and induce the spread of pathology.

  2026cites this paper
• Linking dietary patterns to Alzheimer's disease biomarkers with network mathematical modeling could enable new approach methodologies in preventative AD research: a narrative interdisciplinary review

  2026cites this paper
• Metabolic dysfunction and mitochondrial failure in Alzheimer's disease: integrating pathophysiology, clinical evidence and emerging interventions

  2026cites this paper
• Intercellular communication in the brain via dendritic nanotubular network

  2025cites this paper
• Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery

  2025cites this paper
• Microphysiological engineering of the capillary interface of substantia nigra dopaminergic neurons to study vascular alterations in Parkinson’s Disease

  2025cites this paper
• A peridynamic biochemo-mechanical model for Alzheimer’s Disease

  2025cites this paper
• Maladies à prions ou encéphalopathies spongiformes transmissibles

  2025cites this paper
• Selecting Substitutes for Cranial Dural Repair and Preventing Intracranial Iatrogenic Amyloid Transmission

  2025cites this paper
• Amyloid-beta peptide toxicity in the aged brain is a one-way journey into Alzheimer’s disease

  2025cites this paper
• Amyloid-β modulates the phase separation and aggregation of α-synuclein

  2025cites this paper
• Intracellular trafficking SNARE protein, syntaxin-6, modifies prion cellular phenotypes and risk of disease development in vivo

  2025cites this paper
• The evolving landscape of Alzheimer's disease therapy: From Aβ to tau.

  2025cites this paper
• Aortic Stiffness and Alzheimer’s Disease: The Medin Connection

  2025cites this paper
• Peripheral administration of blood from tau transgenic animals exacerbates brain tau-associated pathology

  2025cites this paper
• Connectivity as a universal predictor of tau progression in atypical Alzheimer’s disease

  2025cites this paper
• Common Mechanism Underlying Synaptic Dysfunction Caused by Preformed Fibril-Induced Accumulation of α-Synuclein or Tau in a Culture Propagation Model

  2025cites this paper
• Intercellular communication in the brain through a dendritic nanotubular network.

  2025cites this paper
• TDP‐43 Phosphorylation: Pathological Modification or Protective Factor Antagonizing TDP‐43 Aggregation in Neurodegenerative Diseases?

  2025cites this paper
• Stochastic Misfolding Drives the Emergence of Distinct α-Synuclein Strains

  2025cites this paper
• Bridging prion biology and Alzheimer’s disease: from pathogenic seeds to precision therapeutics

  2025influential citation
• RNA-seq analyses reveal the relevance of RNAs involved in ribosomal complex to induce mammalian prion protein aggregation and phase separation in vitro

  2025cites this paper
• α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation.

  2025cites this paper
• Hyperphosphorylated tau-based Alzheimer’s Disease drug discovery: Identification of inhibitors of tau aggregation and cytotoxicity

  2025cites this paper
• Extracellular Competing Endogenous RNA Networks Reveal Key Regulators of Early Amyloid Pathology Propagation in Alzheimer’s Disease

  2025cites this paper
• Plant-Based Inhibitors of Protein Aggregation

  2025cites this paper
• Longitudinal Evaluation of the Detection Potential of Serum Oligoelements Cu, Se and Zn for the Diagnosis of Alzheimer’s Disease in the 3xTg-AD Animal Model

  2025cites this paper
• Soluble N-Terminal Domain of the Prion Protein Interferes with Fibrillization of α-Synuclein to Form Off-Pathway Assemblies that Lack Cellular Seeding Activity.

  2025cites this paper
• [Towards using pseudo-prions against neurodegenerative diseases].

  2025cites this paper
• Small HSPs at the crossroad between protein aggregation, autophagy and unconventional secretion: clinical implications and potential therapeutic opportunities in the context of neurodegenerative diseases

  2025cites this paper
• Chronic administration of prebiotics and probiotics prevent pathophysiological hallmarks of Alzheimer’s disease in the cortex of APP/PS1 mice

  2025cites this paper
• Experimental evidence that readily diffusible forms of Aβ from Alzheimer’s disease brain have seeding activity

  2025cites this paper
• Phase Separation Regulates Metabolism, Mitochondria, and Diseases

  2025cites this paper
• The application of fecal microbiota transplantation in Parkinson’s disease

  2025cites this paper
• Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins

  2025cites this paper
• Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies.

  2025cites this paper
• Advances in Intelligent Design and Optimization Methods for Nucleic Acid Sequences

  2025cites this paper
• Dynein‐Dependent Endo‐Lysosomal Degradation Drives Lewy Body Disorders Accompanied by Aβ Pathology

  2025cites this paper
• Amyloid‐β Seeds in Alzheimer's Disease: Research Challenges and Implications

  2025influential citation
• Protein aggregates and biomolecular condensates: implications for human health and disease

  2025cites this paper
• Recent Advances in Co-Condensation and Co-Aggregation of Amyloid Proteins Linked to Neurodegenerative Diseases.

  2025cites this paper
• Early Alzheimer’s Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathy

  2025cites this paper
• Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia‐Dependent Plaque Response in Aged Mice

  2025cites this paper
• Network-dependent cortical thickness reductions following chronic methamphetamine use

  2025cites this paper
• Increased Concentration of Anti-Egg Albumin Antibodies in Cerebrospinal Fluid and Serum of Patients with Alzheimer’s Disease—Discussion on Human Serpins’ Similarity and Probable Involvement in the Disease Mechanism

  2025cites this paper
• Neurodegeneration and aging: pathophysiology, diagnosis, and therapeutic targets

  2025cites this paper
• Polyneuropathy in Parkinson's disease and atypical Parkinsonian syndromes: clinical impact and risk factors.

  2025cites this paper
• Modelling the prion protein-mediated transport of extracellular vesicles on the neuron surface

  2025cites this paper
• Apolipoprotein E gene allele 4 and amyloid-beta mediate tau-related network breakdown

  2025cites this paper
• C-reactive protein: the nexus between inflammation and protein misfolding diseases

  2025cites this paper
• Noninvasive imaging of amyloid‐beta and tau in rodent and nonhuman primate models

  2025cites this paper
• Current Understanding of Protein Aggregation in Neurodegenerative Diseases

  2025cites this paper
• Modulation of O-GlcNAc cycling influences α-synuclein amplification, degradation, and associated neuroinflammatory pathology

  2025cites this paper
• Structural polymorphism of α-synuclein fibrils alters the pathway of Hsc70-mediated disaggregation

  2025cites this paper
• The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases

  2025cites this paper
• BACE1-dependent cleavage of GABAA receptor contributes to neural hyperexcitability and disease progression in Alzheimer's disease.

  2025cites this paper
• A network aggregation model for amyloid-\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\beta $$\end{document}β dynami

  2025cites this paper
• Modeling the prion protein-mediated transport of extracellular vesicles on the neuron surface

  2025cites this paper
• Five Key Criteria for Identifying Optimal Therapeutic Targets in Protein‐Mediated Diseases

  2025cites this paper
• Co‐localization of tau and TDP‐43 after extracellular vesicle delivery to cells

  2025cites this paper
• The Gut-Brain Axis in Alzheimer’s Disease: Exploring Microbial Influences and Therapeutic Strategies

  2025cites this paper
• Protein Misfolding and Aggregation in the Pathogenesis of Alzheimer’s Disease

  2025cites this paper
• The Unfolding Story of Protein Misfolding Causing Alzheimer Disease in Recipients of Human Pituitary Growth Hormone

  2025cites this paper
• Connectomics and neurotransmitter receptor profile explain regional tau pathology in Alzheimer's disease.

  2025cites this paper
• Gut Microbiota and Alzheimer Disease.

  2025cites this paper
• Modelling cerebrovascular pathology and the spread of amyloid beta in Alzheimer’s disease

  2025cites this paper
• In Vivo Seeding of Amyloid-β Protein and Implications in Modeling Alzheimer’s Disease Pathology

  2025cites this paper
• Development of a procedure for prion surveillance in the laboratory setting.

  2025cites this paper
• Exposed Hsp70-binding site impacts yeast Sup35 prion disaggregation and propagation

  2024cites this paper
• The relationship between acrylamide and neurodegenerative diseases: gut microbiota as a new intermediate cue

  2024cites this paper
• Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases

  2024cites this paper
• Aβ remotely and locally facilitates Alzheimer's disease tau spreading.

  2024cites this paper
• PET imaging of microglia in Alzheimer's disease using copper-64 labeled TREM2 antibodies

  2024cites this paper
• A coupled mathematical and numerical model for protein spreading and tissue atrophy, applied to Alzheimer's disease

  2024cites this paper
• Dopamine controls the Sensitivity to Manganese induced Dopaminergic neurotoxicity in Caenorhabditis elegans

  2024cites this paper
• Amyloid-β-targeting immunotherapies for Alzheimer's disease.

  2024cites this paper
• C9orf72 poly-PR forms anisotropic condensates causative of nuclear TDP-43 pathology

  2024cites this paper
• Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways

  2024cites this paper
• Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer’s disease in a APP/PS1 transgenic mouse model

  2024cites this paper
• New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis

  2024cites this paper
• Different folding mechanisms in prion proteins from mammals with different disease susceptibility observed at the single-molecule level

  2024cites this paper
• Two for tau: Automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease

  2024cites this paper
• Exploring the Potential of Probiotics and Prebiotics in Major Depression: From Molecular Function to Clinical Therapy

  2024cites this paper
• Current insights and assumptions on α-synuclein in Lewy body disease

  2024cites this paper
• Intracerebral inoculation of healthy non-transgenic rats with a single aliquot of oligomeric amyloid-β (1–42) profoundly and progressively alters brain function throughout life

  2024cites this paper
• Osmotic stress induces formation of both liquid condensates and amyloids by a yeast prion domain

  2024cites this paper
• A method for the analysis of the oligomerization profile of the Huntington’s disease-associated, aggregation-prone mutant huntingtin protein by isopycnic ultracentrifugation

  2024cites this paper
• No causal relationship between serum urate and neurodegenerative diseases: A Mendelian randomization study.

  2024cites this paper
• In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives

  2024cites this paper
• A discontinuous Galerkin method for the three-dimensional heterodimer model with application to prion-like proteins' dynamics

  2024cites this paper
• Modulating the aggregation of human prion protein PrP106-126 by an indole-based cyclometallated palladium complex.

  2024cites this paper
• Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein

  2024cites this paper